Abstract: Methionine c-lyse (MGL) catalyzes the a, c-elimination of L-methionine and its derivatives as well as the a, b-elimination of L-cysteine and its derivatives to produce a-keto acids, volatile thiols, and ammonia. The reaction mechanism of MGL has been characterized by enzymological studies using several site-directed mutants. The Pseudomonas putida MGL C116H mutant showed drastically reduced degradation activity toward methionine while retaining activity toward homocysteine. To understand the underlying mechanism and to discern the subtle differences between these substrates, we analyzed the crystal structures of the reaction intermediates. The complex formed between the C116H mutant and methionine demonstrated that a loop structure (Ala51-Asn64) in the adjacent subunit of the catalytic dimer cannot approach the cofactor pyridoxal 5 0 -phosphate (PLP) because His116 disrupts the interaction of Asp241 with Lys240, and the liberated side chain of Lys240 causes steric hindrance with this loop. Conversely, in the complex formed between C116H mutant and homocysteine, the thiol moiety of the substrate conjugated with PLP offsets the imidazole ring of His116 via a water molecule, disrupting the interaction of His116 and Asp241 and restoring the interaction of Asp241 with Lys240. These structural data suggest that the Abbreviations: DTT, dl-dithiothreitol; Hcy, homocysteine; MGL, methionine g-lyase; PEG, polyethylene glycol; PLP, pyridoxal 5
Introduction
Sulfur-containing amino acids are essential components of proteins, play critical roles in a variety of biological processes, and are tightly regulated by the methionine cycle and the transsulfuration pathway. 1 In addition to these canonical pathways, some organisms can directly decompose methionine by a pyridoxal 5 0 -phosphate (PLP) enzyme, methionine glyase (MGL; E.C. 4.4.1.11). 2 MGL catalyzes a, gelimination of L-methionine, and its derivatives to produce 2-oxobutyrate, volatile thiols, and ammonia. It also catalyzes a, b-elimination of L-cysteine and its derivatives. 3 In addition, MGL replaces the terminal functional group on the side chain of the substrate to thiol, yielding S-substituted analogues. 3 MGL is found in several lineages of bacteria, parasites, and plants (see review Ref. 2) . MGL has been implicated in energy metabolism in a protozoan parasite, Entameoba histolytica. 4 In Arabidopsis thaliana, it is involved in isoleucine biosynthesis and the formation of S-methylcysteine, a putative sulfide storage molecule. 5 Methanethiol produced by MGL plays a significant role in the pathogenicity of periodontal bacteria. 6 In the bacterium Micromonospora echinospora, MGL is a member of a biosynthetic cluster that produces an antitumor antibiotic. 7 Due to its unique substrate specificity and the absence of an enzyme with similar activity in human, MGL has been exploited in the chemotherapeutic prevention of infection by parasitic protozoa and periodontal bacteria. 8, 9 In addition, recombinant MGL protein has been administered to cause methionine depletion and thus act as an anticancer drug. 10, 11 MGL is also a potential tool for detecting homocysteine in human plasma, and thus can be used to help prevent homocystinuria or atherosclerosis.
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Enzymological studies were performed with wild type and site-directed MGL mutants to understand the enzyme's reaction mechanism. [13] [14] [15] [16] [17] We previously demonstrated that the Cys residue at position 116 (C116) of Pseudomonas putida MGL is important for the a, g-elimination reaction. 14 The C116H mutant exhibits unique futures: the K m of the mutant toward Met increased 1.5-fold compared to wild type but k cat decreased to a negligible level, whereas the K m and k cat values toward homocysteine (Hcy) changed little. 14 Similar enzymological properties have been reported for the equivalent mutant of Citrobacter freundii MGL. 18 The crystal structure of P. putida MGL (PpMGL) shows that the protein is a homotetramer assembled from two catalytic dimers. The structure suggests that Cys116 forms hydrogen bonds with Tyr114, Tyr59*, Arg61*, Lys240*, and Asp241* (asterisks denote amino acid residues in the counterpart subunit) in the vicinity of PLP. 19 These amino acids are well conserved among MGLs and related PLPenzymes. 14 Furthermore, in C. freundii MGL, the phenolate anion of Tyr113 (corresponding to Tyr114 of P. putida MGL) accepts a proton from an a-nitrogen atom of the substrate, leading to the formation of a covalent bond with PLP. 20 In contrast, it is unclear how Cys116 participates in substrate recognition.
In this study, we resolved the crystal structures of the reaction intermediates of wild type and C116H mutant complexed with Met and Hcy, respectively, at resolutions of 1.70-2.70 Å . These structures demonstrated that the substrates were covalently bound to PLP and formed an external aldimine. His116 pushed Arg61* and Tyr59* away from PLP and disrupted formation of the active center. In the Hcy reaction intermediate, however, the thiol group of the Hcy-PLP complex attracted His116 via a water molecule, followed by restoration of the hydrogen bond with Arg61* and Tyr59*, resulting in correct formation of the active center. This catalytic mechanism is an example of substrate-assisted catalysis, in which part of the substrate is actively involved in the formation of the active center. 21 This is the first report of a catalytic mechanism involving substrate-assisted catalysis in a PLP-enzyme.
Results and Discussion
Cys116 remains connected to the a2*/a3* loop to form the active center
We previously demonstrated that the crystal structure of PpMGL is a homotetramer assembled from two catalytic dimers [Supporting Information The cofactor PLP is covalently bound to the e-amino group of Lys211 and interacts through a hydrogen bond with the main chains of Gly89 and Met 90 and with the side chains of Asp186, Ser208, and Thr210 19 [ Fig. 1(a) ]. PLP is covered by the a2*/a3* loop (asterisk denotes the adjacent chain of the catalytic dimer) and interacts with the hydroxyl group of Tyr59* and the guanidium group of Arg61* in this loop. Cys116 connects two halves of a hydrogen bond network, PLP phosphate groupÁÁÁArg61*ÁÁÁTyr114 and Lys240*ÁÁÁAsp241*. A sulfate ion, a component of the crystallization reservoir solution, is bound to the active site and forms hydrogen bonds with Ser340 Na and the side chain of Arg375. These hydrogen bonds appear to stabilize the structure of the substrate-free active site. The sulfate ion additionally interacts with two Tyr residues, Tyr59* and Tyr114, via a water molecule. The active center of the C116H mutant is almost identical to that of the wild type [ Fig. 1(b) ]. The a2*/ a3* loop accesses PLP and its phosphate group interacts with the hydroxyl group of Tyr59* and the guanidium group of Arg61*. The hydrogen bond network sulfate ionÁÁÁwaterÁÁÁTyr59* is also conserved. However, unlike the active center of wild type, His116 interacts with Tyr114 directly at a distance of 3.31 6 0.17 Å (average of four chains 6 S.D.) and the hydrogen bond to Lys240* is lost.
To verify the stabilizing effect of the sulfate ion in the active center, the protein crystal was soaked in cryo-protectant solution lacking ammonium sulfate. The positions of the amino acid residues and the hydrogen bond networks do not change in the absence of the sulfate ion [PDB: 5x2v, Fig. 1(c) ]. This suggests that Cys116 attracts the a2*/a3* loop by interacting with the guanidium group of Arg61* and Try59* can access PLP to form the active center without support from a sulfate ion. Conversely, in the C116H mutant, the hydrogen bonds between PLP pyrimidine N1 and Asp186, and PLP phosphate ion and Gly89, Met90, Ser208, and Thr210 were maintained, whereas the a2*/a3* loop containing Tyr59* and Arg61* protruded from the active center [PDB: 5x2y, Fig. 1(d) ]. The PLP phosphate group interacted with three waters and one of these water molecules interacted with Tyr114. Judging from the distance from the Od atom of Asp241*, the imidazole ring of His116 is flipped as compared to when the sulfate ion is present and forms a hydrogen bond with Asp241* (3.14 6 0.09 Å ). Consequently, the K240* side chain no longer interacts with Asp241*.
The Cys116 to His mutation loses methionine degradation activity due to steric hindrance by Lys240* and Ile62* We prepared crystals of the reaction intermediate by soaking the wild type and C116H mutant crystals in cryo-protectant solution containing 50 mM Met or Hcy. The pH values of the cryo-protectant solutions and the soaking times are described in Supporting Information Table S1 . The structures of the wild type-Met complex (PDB: 5x2w) and of the C116H mutant-Met complex (PDB: 5x2z) demonstrate that the substrate Met covalently binds to PLP and the carboxyl group interacts with the guanidium group of Arg375 and the amino group of Ser340 in all four chains. In the wild type-Met complex, as compared to the ligand-free forms [ Fig. 1(a,c) ], the hydrogen bond of K240* to C116 was absent whereas the hydrogen bond to Asp241* was present [ Fig. 2(a) ]. In the C116H mutant-Met complex, the side chain of Lys240* changed direction because the Nd1 of His116 formed a hydrogen bond to the carboxyl group of Asp241* (2.93 6 0. 20 Å ) [ Fig. 2(b) ], similar to that observed in the ligand-free form without a sulfate ion [ Fig. 1(d)] . Furthermore, the PLP phosphate group and Tyr114 interacted with water molecules. The merged image indicates that the liberated side chain of Lys240* in the C116H mutant-Met complex occupies the position occupied by the secbutyl group of Ile62* in the wild type-Met complex [ Fig. 2(c) ]. These data suggest that the position of the Lys240* side chain, liberated by the interaction of His116 with Asp241*, conflicts with the position of Ile62*, and therefore, Tyr59* and Arg61* locate away from PLP, causing loss of activity toward Met.
The thiol group of Hcy overcomes steric hindrance by attracting His116
The above inactivation mechanism is believed to apply to all substrates; however, the C116H mutant retained activity toward Hcy. 14 In the wild type-Hcy complex (PDB: 5x2x), a hydrogen sulfide released from Hcy-PLP complex interacts with the hydroxyl group of Tyr114 in all four chains (3.17 6 0.20 Å ) [ Fig. 3(a) ]. The structure of the C116H mutant-Hcy complex (PDB: 5x30) shows variation between the four chains: the A and C chains form a Michaelis complex as described previously, 14 whereas the B and D chains form covalent bonds between PLP and the substrate. The structure of the B chain is similar to that of the wild type-Hcy complex, given that the sulfur atom is eliminated from the substrate (data not shown). In the D chain, a water molecule is present in the active center and forms three hydrogen bonds: with the thiol group in the Hcy moiety of PLP-substrate (2.81 Å ), with the hydroxyl group of Tyr114 (3.32 Å ), and with Nd2 of His116 (3.39 Å ) [ Fig. 3(b) ]. Accordingly, the imidazole ring of His116 . The Lys240* side chain does not form a hydrogen bond with Asp241* but occupies a position very close to that of the Ile62* side chain observed in wild type, which changes the structure of the a2*/a3* loop to avoid steric hindrance between the residues.
inclines toward the PLP-substrate complex, and the dihedral angle of the imidazole ring between the Met complex and the Hcy complex is approximately 308. This breaks the interaction between Nd1 and the carboxyl group of Asp241* (calculated distance: 3.93 Å ), the Asp241*ÁÁÁLys240* interaction is reestablished, and access of the a2*/a3* loop to PLP is restored [ Fig. 3(b) ]. The merged stick models of the mutant complexed with Met and with Hcy clearly demonstrate these structural changes [ Fig. 3(c) ].
Conclusions
Our structural analyses of P. putida MGL in complex with Met and Hcy suggest that the Cys116 to His mutation disrupts hydrogen bonds and the active center due to steric hindrance. However, when Hcy binds to PLP, the thiol group of Hcy offsets His116 via a water molecule, restoring catalytic ability. We consider this mechanism to be substrateassisted catalysis because part of the substrate is actively involved in the formation of the catalytic site. 21 The wild type exhibits significant antitumor efficacy by single administration or in combination with the various anticancer drugs. [22] [23] [24] We have not confirmed the efficacy of the C116H mutant which loses the degradation activity toward methionine. However, it is conceivable that homocysteine depletion by the C116H mutant causes the defect of methionine cycle leading to the antitumor effect. Furthermore, the combined application of MGL and tumor-targeting Salmonella might be effective to the quiescent cancer cells. 25 Homocysteine is a representative risk factor of cardiovascular disease. 26 Our data will assist in the design of Hcy-specific degradation enzymes, thus providing potential tools for detecting blood homocysteine levels.
Materials and Methods
P. putida MGL wild type and C116H mutant were crystallized by the sitting-drop vapor-diffusion method, as described previously but with minor modifications. 27 Protein solution (1 lL) was mixed with an equal volume of reservoir solution [200 mM Na-K phosphate buffer (pH 5.6-6.0), 6-10% PEG 6000, 250 mM (NH 4 ) 2 SO 4 , 0.5 mM PLP, and 0.5% (v/v) 2-mercaptoethanol], and the droplet was allowed to equilibrate against 0.1 mL reservoir solution at 293 K for two to three days. A crystal mounted in a nylon loop was briefly soaked in cryo-protectant solution [200 mM Na-K phosphate buffer, 10% PEG 6000, 0.5 mM PLP, 0.5% (v/v) 2-mercaptoethanol, and 20% ethyleneglycol] with or without substrate. The soaking conditions are summarized in Supporting Information Table S1 . The treated crystals were frozen by rapid submersion in liquid nitrogen and stored frozen until use. X-ray diffraction data were collected at 100 K using the BL44XU beamline (SPring-8; Harima, Japan) and an in-house X-ray source (Rigaku MicroMax-007 HF). All datasets were integrated and scaled using HKL2000 and SCALEPACK. 28 The structures were determined by molecular replacement using the structure of P. putida MGL (PDB: 2o7c) 19 as a search model. The Molrep program 29 implemented within the CCP4 package 30 was used.
To determine the structures of the reaction intermediates, the initial stage of refinement was conducted using the Refmac5 program. 31 Further refinement using Refmac5 and manual model correction using Coot 32 based on the |2F o -F c | map were repeated, and the structures were finally determined using the TLS-refinement protocol in Refmac5. Average B-factors and Ramachandran plots are included in Supporting Information Table S1 . Molecular graphics were prepared using PyMOL v.1.8 (http:// www.pymol.org/).
